Divi’s Laboratories’ net profit rose 151.5% to Rs 67.28 crore in Q1 June 2007 over Q1 June 2006. Sales moved up 41.8% to Rs 228.07 crore in Q1 June 2007 over Q1 June 2006.
Hyderabad-based Divi’s Labs makes generic bulk drugs and offers customs chemical synthesis or drug development services to innovator drug firms.
Aditya Birla Nuvo’s net profit slid 53% to Rs 26.46 crore in Q1 June 2007 over Q1 June 2006. Sales declined 5.4% to Rs 740.96 in Q1 June 2007 over Q1 June 2006.
Aditya Birla Nuvo’s principal activities are manufacturing viscose filament yarn, carbon black, branded apparels, textiles and insulators.